Dr. Daniel A. Popa, MD, PhD

Dr. Popa practices at Hennepin County Medical Center in Minneapolis, Minnesota, part of Hennepin County.

Dr. Popa's NPI, 1114276706, was assigned on August 29, 2012. Dr. Popa graduated from University of California, San Diego School of Medicine in 2012. Dr. Popa holds Minnesota license 68902.

Dr. Popa's primary practice is Hennepin County Medical Center, at 701 Park Avenue, Minneapolis, MN 55415 in Hennepin County. The practice phone is (612) 873-3000.

Dr. Popa's primary practice is Hennepin County Medical Center in Minneapolis, Minnesota, part of Hennepin County. Dr. Popa is also affiliated with M Health Fairview University of Minnesota Medical Center. The medical group on file is Fairview Health Services. Dmand AI also links Dr. Popa to 1 more hospital and 7 medical groups, each named with a free account. Dr. Popa's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Popa practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Popa's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Popa is licensed in Minnesota.

CMS data shows 275 Medicare services from Dr. Popa across 4 procedure codes in 2024, for 95 Medicare patients. Medicare paid $21,233 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 95 Medicare patients who saw Dr. Popa in 2024. The largest group is under 65, with 36 patients. 74% of them have high blood pressure, and 68% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Popa's median patient age at 48, with 39% women.

In 2024, Dr. Popa wrote 39 Medicare Part D claims for 29 patients. 90% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $92 in total drug cost. In 2018, CMS named 41 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Popa for performance year 2024, reported as part of a group. Dr. Popa accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Popa, published from 2016 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Diving, Hyperbaric Oxygenation and COVID-19. Dr. Popa has published most often in J Emerg Med. Dr. Popa's most frequent co-authors are Ian R. Grover, MD, Christopher John Logue, MD and Charlotte Anne Sadler, MD.

CMS Open Payments shows 1 general payment to Dr. Popa from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $12.

Dr. Popa graduated from University of California, San Diego School of Medicine in 2012.